Literature DB >> 10092696

Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

J Wahlström1, M Berlin, C M Sköld, H Wigzell, A Eklund, J Grunewald.   

Abstract

BACKGROUND: The granulomatous inflammation in sarcoidosis is driven by the interplay between T cells and macrophages. To gain a better understanding of this process the expression by these cells of cell surface activation markers, co-stimulatory molecules, and adhesion molecules was analysed.
METHODS: CD4+ and CD8+ T lymphocytes from peripheral blood (PBL) or bronchoalveolar lavage (BAL) fluid, as well as paired peripheral blood monocytes and alveolar macrophages from 27 patients with sarcoidosis were analysed by flow cytometry.
RESULTS: CD26, CD54, CD69, CD95, and gp240 were all overexpressed in T cells from BAL fluid compared with those from PBL in both the CD4+ and CD8+ subsets, while CD57 was overexpressed only in BAL CD4+ cells. In contrast, CD28 tended to be underexpressed in the BAL T cells. Monocyte/macrophage markers included CD11a, CD11b, CD11c, CD14, CD16, CD54, CD71, CD80 and CD86 and HLA class II. CD11a expression in alveolar macrophages (and peripheral blood monocytes) was increased in patients with active disease and correlated positively with the percentage of BAL lymphocytes. Expression of CD80 in macrophages correlated with the BAL CD4/CD8 ratio.
CONCLUSIONS: Our data indicate substantial activation of both CD4+ and CD8+ lung T cells in sarcoidosis. There were also increased numbers of BAL lymphocytes whose phenotypic characteristics have earlier been associated with clonally expanded, replicatively senescent cells of the Th1 type.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092696      PMCID: PMC1745457          DOI: 10.1136/thx.54.4.339

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  44 in total

1.  Antigen-presenting capacity in patients with sarcoidosis.

Authors:  Y Ina; K Takada; M Yamamoto; M Morishita; A Miyachi
Journal:  Chest       Date:  1990-10       Impact factor: 9.410

2.  Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding.

Authors:  C R Lyons; E J Ball; G B Toews; J C Weissler; P Stastny; M F Lipscomb
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

3.  T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1.

Authors:  C Saltini; M E Hemler; R G Crystal
Journal:  Clin Immunol Immunopathol       Date:  1988-02

4.  Increased expression of leukocyte function associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) by alveolar macrophages of patients with pulmonary sarcoidosis.

Authors:  M Melis; M Gjomarkaj; E Pace; G Malizia; M Spatafora
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

5.  Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis.

Authors:  A Eklund; E Blaschke
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

6.  Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosis.

Authors:  D Lecossier; D Valeyre; A Loiseau; J Cadranel; A Tazi; J P Battesti; A J Hance
Journal:  Am Rev Respir Dis       Date:  1991-10

7.  Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.

Authors:  V M Lem; M F Lipscomb; J C Weissler; G Nunez; E J Ball; P Stastny; G B Toews
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

8.  Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  J Müller-Quernheim; C Saltini; P Sondermeyer; R G Crystal
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

9.  CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.

Authors:  A J Ulmer; T Mattern; A C Feller; E Heymann; H D Flad
Journal:  Scand J Immunol       Date:  1990-04       Impact factor: 3.487

10.  Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.

Authors:  L I Roman; L Manzano; A De La Hera; L Abreu; I Rossi; M Alvarez-Mon
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  24 in total

1.  In vitro immunogenic and immunostimulatory effects of zwitterionized 23-valent pneumococcal polysaccharide vaccine compared with nonzwitterionized vaccine.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Fatimah Abubaker
Journal:  Curr Ther Res Clin Exp       Date:  2010-02

2.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

Review 4.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

Review 5.  Dendritic Cell Trafficking and Function in Rare Lung Diseases.

Authors:  Huan Liu; Claudia Jakubzick; Andrew R Osterburg; Rebecca L Nelson; Nishant Gupta; Francis X McCormack; Michael T Borchers
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

6.  Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.

Authors:  T Kurumagawa; S Seki; H Kobayashi; Y Koike; S Kanoh; H Hiraide; K Motoyoshi
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.

Authors:  H Stridh; A Planck; D Gigliotti; A Eklund; J Grunewald
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 8.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

9.  T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?

Authors:  M Heron; A M E Claessen; J C Grutters; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

Review 10.  Is CD69 an effective brake to control inflammatory diseases?

Authors:  Roberto González-Amaro; José R Cortés; Francisco Sánchez-Madrid; Pilar Martín
Journal:  Trends Mol Med       Date:  2013-08-13       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.